SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
In business, the power of individual leaders is an inherently hard thing to measure. It’s subjective, and it fluctuates on ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Since 2013, there have been metaphorically for programmers to build annual rankings of the world’s most popular programming languages. The rankings have traditionally relied on public signals such as ...
The SoFi NBA Play-In Tournament features the Nos. 7-10 teams in each conference battling for the 7th and 8th playoff seeds. • Download the NBA App • 2025 NBA Play-In, Playoffs & Final Schedule The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback